Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 113

1.

Liver transplantation for hepatocellular carcinoma in clinical practice: the lesson from a 20-year multicentre experience in Italy.

Farinati F, Giacomin A, Vanin V, Sergio A, Burra P, Cillo U, Di Nolfo A, Del Poggio P, Benvegnu L, Zoli M, Borzio F, Giannini EG, Caturelli E, Cazzagon N, Rapaccini GL, Trevisani F; Italian Liver Cancer (ITA.LI.CA) group.

Eur J Gastroenterol Hepatol. 2012 Feb;24(2):195-202. doi: 10.1097/MEG.0b013e32834e153c.

PMID:
22108511
2.

Partial hepatectomy as first-line treatment for patients with hepatocellular carcinoma.

Cillo U, Vitale A, Brolese A, Zanus G, Neri D, Valmasoni M, Bonsignore P, Grigoletto F, Burra P, Farinati F, D'Amico DF.

J Surg Oncol. 2007 Mar 1;95(3):213-20.

PMID:
17066432
3.

Liver transplantation for hepatocellular carcinoma: Hangzhou experiences.

Zheng SS, Xu X, Wu J, Chen J, Wang WL, Zhang M, Liang TB, Wu LM.

Transplantation. 2008 Jun 27;85(12):1726-32. doi: 10.1097/TP.0b013e31816b67e4.

PMID:
18580463
4.

HCC in living donor liver transplantation: can we expand the Milan criteria?

Kwon CH, Kim DJ, Han YS, Park JB, Choi GS, Kim SJ, Joh JW, Lee SK.

Dig Dis. 2007;25(4):313-9.

PMID:
17960066
5.

Rate of tumor growth predicts recurrence of hepatocellular carcinoma after liver transplantation in patients beyond Milan or UCSF criteria.

Hanouneh IA, Macaron C, Lopez R, Aucejo F, Zein NN.

Transplant Proc. 2011 Dec;43(10):3813-8. doi: 10.1016/j.transproceed.2011.09.043.

PMID:
22172852
6.

[Indication of liver transplantation for hepatocellular carcinoma: Shanghai Fudan Criteria].

Fan J, Zhou J, Xu Y, Qiu SJ, Wu ZQ, Yu Y, Huang XW, Tang ZY, Wang YQ.

Zhonghua Yi Xue Za Zhi. 2006 May 16;86(18):1227-31. Chinese.

PMID:
16796876
7.

Resection for hepatocellular carcinoma is a good option in Child-Turcotte-Pugh class A patients with cirrhosis who are eligible for liver transplantation.

Margarit C, Escartín A, Castells L, Vargas V, Allende E, Bilbao I.

Liver Transpl. 2005 Oct;11(10):1242-51.

8.

Patients with unresectable hepatocellular carcinoma beyond Milan criteria: should we perform transarterial chemoembolization or liver transplantation?

Kim JM, Kwon CH, Joh JW, Kim SJ, Shin M, Kim EY, Moon JI, Jung GO, Choi GS, Lee SK.

Transplant Proc. 2010 Apr;42(3):821-4. doi: 10.1016/j.transproceed.2010.02.027.

PMID:
20430181
9.

Predictors of long-term survival after liver transplantation for hepatocellular carcinoma.

Zavaglia C, De Carlis L, Alberti AB, Minola E, Belli LS, Slim AO, Airoldi A, Giacomoni A, Rondinara G, Tinelli C, Forti D, Pinzello G.

Am J Gastroenterol. 2005 Dec;100(12):2708-16.

PMID:
16393224
10.

[Prognostic factors of hepatocellular carcinoma after liver transplantation].

Zhou LX, Yan LN.

Ai Zheng. 2006 Jun;25(6):736-9. Chinese.

PMID:
16764771
11.

Extended indication for living donor liver transplantation in patients with hepatocellular carcinoma.

Soejima Y, Taketomi A, Yoshizumi T, Uchiyama H, Aishima S, Terashi T, Shimada M, Maehara Y.

Transplantation. 2007 Apr 15;83(7):893-9.

PMID:
17460559
12.

Liver transplantation is an alternative treatment of hepatocellular carcinoma beyond the Milan criteria.

Fan HL, Chen TW, Hsieh CB, Jan HC, His SC, De-Chuan C, Chu CH, Yu JC.

Am J Surg. 2010 Aug;200(2):252-7. doi: 10.1016/j.amjsurg.2009.07.049. Epub 2010 Feb 1.

PMID:
20122677
13.

Morphological features of advanced hepatocellular carcinoma as a predictor of downstaging and liver transplantation: an intention-to-treat analysis.

Barakat O, Wood RP, Ozaki CF, Ankoma-Sey V, Galati J, Skolkin M, Toombs B, Round M, Moore W, Mieles L.

Liver Transpl. 2010 Mar;16(3):289-99. doi: 10.1002/lt.21994.

14.

Liver transplantation in patients with hepatocellular carcinoma across Milan criteria.

Herrero JI, Sangro B, Pardo F, Quiroga J, Iñarrairaegui M, Rotellar F, Montiel C, Alegre F, Prieto J.

Liver Transpl. 2008 Mar;14(3):272-8. doi: 10.1002/lt.21368.

15.

The impact of Milan criteria on liver transplantation for hepatocellular carcinoma: first 15 years' experience of the Hungarian Liver Transplant Program.

Nemes B, Gelley F, Piros L, Zádori G, Görög D, Fehérvári I, Kóbori L, Sárváry E, Nagy P, Kiss A, Doros A.

Transplant Proc. 2011 May;43(4):1272-4. doi: 10.1016/j.transproceed.2011.03.077.

PMID:
21620108
16.
17.
18.

Utility-based criteria for selecting patients with hepatocellular carcinoma for liver transplantation: A multicenter cohort study using the alpha-fetoprotein model as a survival predictor.

Vitale A, Farinati F, Burra P, Trevisani F, Giannini EG, Ciccarese F, Piscaglia F, Rapaccini GL, Di Marco M, Caturelli E, Zoli M, Borzio F, Cabibbo G, Felder M, Sacco R, Morisco F, Missale G, Foschi FG, Gasbarrini A, Svegliati Baroni G, Virdone R, Chiaramonte M, Spolverato G, Cillo U; Italian Liver Cancer Group.

Liver Transpl. 2015 Oct;21(10):1250-8. doi: 10.1002/lt.24214.

19.

Liver transplantation for hepatocellular carcinoma and cirrhosis in candidates with undetectable or very low alpha-fetoprotein levels: is an expansion of the listing criteria justified?

Sotiropoulos GC, Malagó M, Bockhorn M, Schmitz KJ, Radtke A, Molmenti EP, Schaffer R, Beckebaum S, Cicinnati VR, Fouzas I, Broelsch CE, Lang H.

Hepatogastroenterology. 2008 Sep-Oct;55(86-87):1671-7.

PMID:
19102367
20.

Liver transplantation for hepatocellular carcinoma in patients who do not meet the Milan criteria.

Suh KS, Cho EH, Lee HW, Shin WY, Yi NJ, Lee KU.

Dig Dis. 2007;25(4):329-33.

PMID:
17960068

Supplemental Content

Support Center